LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

by Business Wire • 2022/03/03 • 0 Comments

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter and full year ended December 31, 2021 and provided an update on key strategic and operational initiatives. “2021 was a year of progress for LENSAR. Revenue and procedure volume in 2021 returned to our historical record of over 20% annu

← El método OPTRACT: proeza en el transporte eficiente de la córnea de un donante humano y repositorio de células futuristas en gravedad cero para la investigación antienvejecimiento de la era espacial; estrategia de científicos japoneses.

O método OPTRACT: proeza eficiente de transporte de córnea de doador humano e repositório de células futurista em gravidade zero para pesquisa antienvelhecimento e da era espacial; estratégia de cientistas japoneses. →

Post navigation